专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US09114155B2 Composition containing jetbead extracts 有权
标题翻译：含有喷射提取物的组合物
公开(公告)号：US09114155B2
公开(公告)日：2015-08-25
申请号：US14009596
申请日：2012-04-06
申请人： Won Gon Kim , Baek Soo Han , Kyoung Shim Kim , Kwang Soo Kim , Young Mi Kang , Chun Hyung Kim , Mi Jin Sohn , Hoe Yune Jung
发明人： Won Gon Kim , Baek Soo Han , Kyoung Shim Kim , Kwang Soo Kim , Young Mi Kang , Chun Hyung Kim , Mi Jin Sohn , Hoe Yune Jung
IPC分类号： A61K36/73 , A61K36/738
CPC分类号： A61K36/73 , A61K36/738
摘要： The present invention relates to a pharmaceutical composition for preventing or treating Parkinson's disease, which comprises, as an active ingredient, a Rhodotypos scandens extract obtained by extracting the stem of Rhodotypos scandens with an organic solvent, and a food additive showing the effect of preventing or treating Parkinson's disease, the food additive comprising Rhodotypos scandens extract as an active ingredient. The Rhodotypos scandens extracts of the present invention may prevent or treat Parkinson's disease without producing any particular side effects, and therefore can be widely used for more safely treating Parkinson's disease.
摘要翻译：本发明涉及一种用于预防或治疗帕金森病的药物组合物，其包含作为活性成分的通过用有机溶剂提取红景天甙茎的获得的红景霉素提取物，以及显示出预防或治疗帕金森病，食品添加剂包含红景天提取物作为活性成分。本发明的红景天提取物可以预防或治疗帕金森氏病，而不产生任何特定的副作用，因此可广泛用于更安全地治疗帕金森病。

2. 发明申请

US20140370132A1 COMPOSITION CONTAIING JETBEAD EXTRACTS 有权
标题翻译：含有JETBEAD提取物的组合物
公开(公告)号：US20140370132A1
公开(公告)日：2014-12-18
申请号：US14009596
申请日：2012-04-06
申请人： Won Gon Kim , Baek Soo Han , Kyoung Shim Kim , Kwang Soo Kim , Young Mi Kang , Chun Hyung Kim , Mi Jin Sohn , Hoe Yune Jung
发明人： Won Gon Kim , Baek Soo Han , Kyoung Shim Kim , Kwang Soo Kim , Young Mi Kang , Chun Hyung Kim , Mi Jin Sohn , Hoe Yune Jung
IPC分类号： A61K36/73
CPC分类号： A61K36/73 , A61K36/738
摘要： The present invention relates to a pharmaceutical composition for preventing or treating Parkinson's disease, which comprises, as an active ingredient, a Rhodotypos scandens extract obtained by extracting the stem of Rhodotypos scandens with an organic solvent, and a food additive showing the effect of preventing or treating Parkinson's disease, the food additive comprising Rhodotypos scandens extract as an active ingredient. The Rhodotypos scandens extracts of the present invention may prevent or treat Parkinson's disease without producing any particular side effects, and therefore can be widely used for more safely treating Parkinson's disease.
摘要翻译：本发明涉及一种用于预防或治疗帕金森病的药物组合物，其包含作为活性成分的通过用有机溶剂提取红景天甙茎的获得的红景霉素提取物，以及显示出预防或治疗帕金森病，食品添加剂包含红景天提取物作为活性成分。本发明的红景天提取物可以预防或治疗帕金森氏病，而不产生任何特定的副作用，因此可广泛用于更安全地治疗帕金森病。

3. 发明申请

US20090253617A1 DIAGNOSIS AND TREATMENT OF ATTENTIONAL DISORDERS 有权
标题翻译：诊断和治疗注意事项
公开(公告)号：US20090253617A1
公开(公告)日：2009-10-08
申请号：US11674817
申请日：2007-02-14
申请人： Kwang-Soo Kim , Chun-Hyung Kim
发明人： Kwang-Soo Kim , Chun-Hyung Kim
IPC分类号： A61K38/16 , C07H21/02 , C12Q1/68 , A61K31/7088 , A61P25/00
CPC分类号： C12Q1/6883 , C12Q2600/106 , C12Q2600/136 , C12Q2600/156
摘要： This invention features methods and compositions useful for the treatment and diagnosis of attentional disorders including attention deficit hyperactivity disorder (ADHD). Also disclosed are methods for identifying compounds useful for such therapy.
摘要翻译：本发明的特征在于可用于治疗和诊断包括注意缺陷多动障碍（ADHD）在内的注意障碍的方法和组合物。还公开了鉴定可用于此类治疗的化合物的方法。

4. 发明申请

US20090226401A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE 有权
标题翻译：用于治疗帕金森病的方法和组合物
公开(公告)号：US20090226401A1
公开(公告)日：2009-09-10
申请号：US12279473
申请日：2007-02-15
申请人： Deog Joong Kim , Chun Hyung Kim , Kwang Soo Kim
发明人： Deog Joong Kim , Chun Hyung Kim , Kwang Soo Kim
IPC分类号： A61K35/12 , A61K31/4706 , C12N5/06 , C12N5/08 , C12Q1/68 , C12Q1/02 , C12Q1/26
CPC分类号： A61K31/4706
摘要： The invention features methods and kits for treating or inhibiting the development of Parkinson's Disease by administering 7-chloro-4-aminoquinoline compounds, e.g., amodiaquine or glafenine. Stem cells are also useful in the methods of the invention and may be administered separately from or together with 7-chloro-4-aminoquinoline compounds. The invention further features methods of identifying additional chemical compounds that are useful in the treatment or inhibition of the development of Parkinson's Disease.
摘要翻译：本发明的特征在于通过施用7-氯-4-氨基喹啉化合物，例如阿莫地喹或格拉芬而治疗或抑制帕金森病发展的方法和试剂盒。干细胞也可用于本发明的方法，并且可以与7-氯-4-氨基喹啉化合物分开或一起施用。本发明还涉及鉴定可用于治疗或抑制帕金森病发展的其它化学化合物的方法。

5. 发明授权

US08114892B2 Methods and compositions for the treatment of Parkinson's Disease 有权
标题翻译：用于治疗帕金森病的方法和组合物
公开(公告)号：US08114892B2
公开(公告)日：2012-02-14
申请号：US12279473
申请日：2007-02-15
申请人： Deog Joong Kim , Chun Hyung Kim , Kwang Soo Kim
发明人： Deog Joong Kim , Chun Hyung Kim , Kwang Soo Kim
IPC分类号： A61K31/4706 , A61P25/16 , A61P33/06
CPC分类号： A61K31/4706
摘要： The invention features methods and kits for treating or inhibiting the development of Parkinson's Disease by administering 7-chloro-4-aminoquinoline compounds, e.g., amodiaquine or glafenine. Stem cells are also useful in the methods of the invention and may be administered separately from or together with 7-chloro-4-aminoquinoline compounds. The invention further features methods of identifying additional chemical compounds that are useful in the treatment or inhibition of the development of Parkinson's Disease.
摘要翻译：本发明的特征在于通过施用7-氯-4-氨基喹啉化合物，例如阿莫地喹或格拉芬而治疗或抑制帕金森病发展的方法和试剂盒。干细胞也可用于本发明的方法，并且可以与7-氯-4-氨基喹啉化合物分开或一起施用。本发明还涉及鉴定可用于治疗或抑制帕金森病发展的其它化学化合物的方法。

6. 发明授权

US06538126B1 Hepatitis C diagnostics and vaccines 失效
标题翻译：丙型肝炎诊断和疫苗
公开(公告)号：US06538126B1
公开(公告)日：2003-03-25
申请号：US08150204
申请日：1994-04-20
申请人： Joong Myung Cho , Yong Beom Lee , Young Woo Park , Kook Jin Lim , Deog Young Choi , Hong Seob So , Chun Hyung Kim , Sung Taek Kim , Jae Young Yang
发明人： Joong Myung Cho , Yong Beom Lee , Young Woo Park , Kook Jin Lim , Deog Young Choi , Hong Seob So , Chun Hyung Kim , Sung Taek Kim , Jae Young Yang
IPC分类号： C07H2104
CPC分类号： C07K14/005 , A61K39/00 , C07K16/109 , C12N2770/24222 , Y10S530/826
摘要： The present invention provides polynucleotides derived from cDNA of novel type of hepatitis C virus named Korean type hepatitis C virus (KHCV), polypeptides encoded therein, and antibodies directed against the polypeptides; and also provide diagnostics and vaccines employing any of the above materials as active ingredient(s).
摘要翻译：本发明提供衍生自名为韩国型丙型肝炎病毒（KHCV）的新型丙型肝炎病毒的cDNA的多核苷酸，其中编码的多肽和针对多肽的抗体; 并且还提供使用任何上述材料作为活性成分的诊断和疫苗。

7. 发明授权

US09034916B2 Pharmaceutical composition for the prevention or treatment of a neurodegenerative disease, comprising a Daphne genkwa extract or a compound isolated therefrom 有权
标题翻译：用于预防或治疗神经变性疾病的药物组合物，包含达芙妮genkwa提取物或从其分离的化合物
公开(公告)号：US09034916B2
公开(公告)日：2015-05-19
申请号：US14009526
申请日：2011-11-28
申请人： Won Gon Kim , Baek Soo Han , Kyoung Shim Kim , Kwang Soo Kim , Young Mi Kang , Yu Jin Kim , Chun Hyung Kim , Mi Jin Sohn , Hoe Yune Jung
发明人： Won Gon Kim , Baek Soo Han , Kyoung Shim Kim , Kwang Soo Kim , Young Mi Kang , Yu Jin Kim , Chun Hyung Kim , Mi Jin Sohn , Hoe Yune Jung
IPC分类号： A01N43/02 , A61K31/335 , A01N43/08 , A61K31/34 , A01N37/00 , A61K31/21 , A01N31/14 , A61K31/075 , A01N31/00 , A61K31/045 , A61K31/357 , A61K36/83
CPC分类号： A61K31/357 , A61K36/83
摘要： The present invention relates to: a pharmaceutical composition or a Nurr1 activating composition for the prevention or treatment of a neurodegenerative disease or a disease induced by impaired Nurr1 function, wherein the composition comprises an active ingredient in the form of genkwanin N or yuanhuacine, a Daphne genkwa extract comprising one or more of the above compounds, or a fraction thereof; or a functional food additive for preventing or alleviating a neurodegenerative disease or a disease induced by impaired Nurr1 function, wherein the additive comprises genkwanin N or yuanhuacine, a Daphne genkwa extract comprising one or more of the above compounds, or a fraction thereof; and a method for the prevention or treatment of a neurodegenerative disease or a disease induced by impaired Nurr1 function, wherein the method comprises the step of administering the pharmaceutical composition.
摘要翻译：本发明涉及：用于预防或治疗神经退行性疾病或由Nurr1功能受损引起的疾病的药物组合物或Nurr1活化组合物，其中所述组合物包含以genkwanin N或元花胺形式的活性成分，达芙妮 genkwa提取物包含一种或多种上述化合物或其一部分; 或用于预防或减轻神经退行性疾病或由Nurr1功能受损引起的疾病的功能性食品添加剂，其中所述添加剂包括genkwanin N或元华辛，包含一种或多种上述化合物的Daphne genkwa提取物或其一部分; 以及用于预防或治疗由Nurr1功能受损引起的神经变性疾病或疾病的方法，其中所述方法包括施用所述药物组合物的步骤。

8. 发明申请

US20120128655A1 INDUCED PLURIPOTENT STEM CELLS 审中-公开
标题翻译：诱导的大脑干细胞
公开(公告)号：US20120128655A1
公开(公告)日：2012-05-24
申请号：US13260897
申请日：2010-04-01
申请人： Dohoon Kim , Chun-Hyung Kim , Kwang-Soo Kim
发明人： Dohoon Kim , Chun-Hyung Kim , Kwang-Soo Kim
IPC分类号： C12N5/071 , A61K8/98
CPC分类号： C12N5/0696 , C12N2501/602 , C12N2501/603 , C12N2501/604 , C12N2501/606
摘要： The present invention concerns the delivery of certain reprogramming factor proteins into cells, such as differenti-atedsomatic cells, in order to induce the epi-genetic reprogramming of the cell so it becomes a pluripotent stem cell. The reprogramming factor protein(s) may be Sox2, Klf4, Oct3/4, c-Myc, Lin28, Nanog, or any protein with reprogramming (-enhancing) activity. These proteins may be linked recombinantly or chemically to a cell penetrating peptide that helps facilitate the introduction of these proteins into the target cell and may be preferably expressed in mammalian cells to maintain them in active forms. Accordingly, the present method of inducing pluripotent stem cell (iPS) formation avoids the use of viral or DNA-based expression vectors or the expression of reprogramming factor genes within target cells, which are known to be harmful to the host target cell and cause cancer.
摘要翻译：本发明涉及将某些重编程因子蛋白递送到细胞中，例如分化细胞，以便诱导细胞的外显重编程，使其成为多能干细胞。重编程因子蛋白可以是Sox2，Klf4，Oct3 / 4，c-Myc，Lin28，Nanog或具有重编程（增强）活性的任何蛋白质。这些蛋白质可以重组或化学地连接到细胞穿透肽，这有助于促进将这些蛋白质引入靶细胞，并且可优选在哺乳动物细胞中表达以维持它们为活性形式。因此，本发明的诱导多能干细胞（iPS）形成的方法避免了使用基于病毒或DNA的表达载体或靶细胞中重编程因子基因的表达，其已知对宿主靶细胞有害并引起癌症。

9. 发明授权

US07807362B2 Diagnosis of attention deficit hyperactivity disorder 有权
标题翻译：注意缺陷多动障碍的诊断
公开(公告)号：US07807362B2
公开(公告)日：2010-10-05
申请号：US11674817
申请日：2007-02-14
申请人： Kwang-Soo Kim , Chun-Hyung Kim
发明人： Kwang-Soo Kim , Chun-Hyung Kim
IPC分类号： C12Q1/68 , C12Q1/00 , G01N33/566 , G01N33/567
CPC分类号： C12Q1/6883 , C12Q2600/106 , C12Q2600/136 , C12Q2600/156
摘要： This invention features methods and compositions useful for the treatment and diagnosis of attentional disorders including attention deficit hyperactivity disorder (ADHD). Also disclosed are methods for identifying compounds useful for such therapy.
摘要翻译：本发明的特征在于可用于治疗和诊断包括注意缺陷多动障碍（ADHD）在内的注意障碍的方法和组合物。还公开了鉴定可用于此类治疗的化合物的方法。

10. 发明授权

US5910405A HCV diagnostic agents 失效
标题翻译： HCV诊断剂
公开(公告)号：US5910405A
公开(公告)日：1999-06-08
申请号：US537811
申请日：1995-10-24
申请人： Joong Myung Cho , Deog Young Choi , Chun Hyung Kim , Hong Seob So , Jae Young Yang , In Soo Kim , Joo Ho Kim
发明人： Joong Myung Cho , Deog Young Choi , Chun Hyung Kim , Hong Seob So , Jae Young Yang , In Soo Kim , Joo Ho Kim
IPC分类号： C12Q1/68 , A61K39/00 , C07H21/04 , C07K14/18 , C12N1/21 , C12N15/09 , C12N15/51 , C12P21/02 , C12R1/19 , G01N33/576 , C12Q1/70 , G01N33/53
CPC分类号： C07K14/005 , G01N33/5767 , A61K39/00 , C12N2770/24222 , Y10S530/811 , Y10S530/826
摘要： The present invention relates to the epitopes of hepatitis C virus (HCV) core protein and non-structural 3 protein (NS3), and the epitopes of envelope protein, epitopes of non-structural 4 protein, and the epitopes of HCV non-structural 5 protein and a recombinant protein comprising the same; processes for producing the recombinant proteins; an agent for diagnosing antibodies against hepatitis C virus in a putative serum sample, which comprises said recombinant proteins; and a process for diagnosing hepatitis C by using the agent.
摘要翻译： PCT No.PCT / KR94 / 00040 Sec。 371日期1995年10月24日第 102（e）日期1995年10月24日PCT 1994年4月29日PCT PCT。公开号WO94 / 25486 日期：1994年11月10日本发明涉及丙型肝炎病毒（HCV）核心蛋白和非结构性3蛋白（NS3）的表位，以及包膜蛋白的表位，非结构性4蛋白的表位，以及 HCV非结构5蛋白和包含其的重组蛋白; 生产重组蛋白的方法; 用于在推定的血清样品中诊断丙型肝炎病毒抗体的试剂，其包含所述重组蛋白; 以及通过使用该药剂来诊断丙型肝炎的过程。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式